Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Strategies for gene therapy

R M Blaese1, C A Mullen, W J Ramsey

  • 1Cellular Immunology Section, Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

Pathologie-Biologie
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GAP JUNCTION FUNCTION IS ESSENTIAL FOR SURVIVAL OF ACUTE LYMPHOBLASTIC LEUKEMIA CELLS.

Experimental oncology·2024
Same author

Background characterization of an ultra-low background liquid scintillation counter.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2017
Same author

Osteocyte differentiation and the formation of an interconnected cellular network in vitro.

European cells & materials·2016
Same author

Development of a low background liquid scintillation counter for a shallow underground laboratory.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2015
Same author

Bone cell mechanosensation of fluid flow stimulation: a fluid-structure interaction model characterising the role integrin attachments and primary cilia.

Biomechanics and modeling in mechanobiology·2014
Same author

Cell morphology and focal adhesion location alters internal cell stress.

Journal of the Royal Society, Interface·2014

Retroviral gene therapy shows promise for treating diseases like melanoma and SCID. This approach enables stable gene expression in T cells, leading to immune reconstitution and new therapeutic avenues.

Area of Science:

  • Gene therapy
  • Immunotherapy
  • Oncology

Background:

  • Retroviral-mediated gene transfer enables DNA labeling of T cells for immunotherapy.
  • Gene therapy offers potential for inherited and acquired diseases.

Purpose of the Study:

  • To demonstrate the clinical application of gene therapy using retroviral vectors.
  • To evaluate the efficacy of gene therapy in treating severe combined immunodeficiency (SCID) and other cancers.

Main Methods:

  • Ex vivo gene transfer into T cells (TIL) and CD34+ stem cells.
  • Utilizing retroviral vectors for stable gene expression.
  • Developing autologous tumor vaccines with cytokine gene-modified tumor cells.

Main Results:

Related Experiment Videos

  • Achieved long-term, stable expression of exogenous genes in human T lymphocytes.
  • Demonstrated significant immune reconstitution in ADA-deficient SCID patients.
  • Showcased potential for treating brain tumors via herpes thymidine kinase gene transfer.

    • Conclusions:

    • Retroviral gene therapy is a viable approach for treating various diseases, including SCID and cancer.
    • Ex vivo gene therapy can lead to stable gene expression and immune reconstitution.
    • Emerging applications include stem cell gene therapy and targeted cancer treatments.